Evid Based Spine Care J 2014; 05(02): 151-157
DOI: 10.1055/s-0034-1387804
Case Report
Georg Thieme Verlag KG Stuttgart · New York

L4 and L5 Spondylectomy for En Bloc Resection of Giant Cell Tumor and Review of the Literature

David R. Santiago-Dieppa
1   Department of Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
,
Lee S. Hwang
1   Department of Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
,
Ali Bydon
1   Department of Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
,
Ziya L. Gokaslan
1   Department of Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
,
Edward F. McCarthy
2   Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
,
Timothy F. Witham
1   Department of Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
› Author Affiliations
Further Information

Publication History

23 December 2013

08 July 2014

Publication Date:
24 September 2014 (online)

Abstract

Study Design Case report and review of the literature.

Objective We present the case of a two-level lumbar spondylectomy at L4 and L5 for en bloc resection of a giant cell tumor (GCT) and lumbopelvic reconstruction.

Methods A 58-year-old woman presented with a 7-month history of progressive intractable back and leg pain secondary to a biopsy-proven Enneking stage III GCT of the L4 and L5 vertebrae. The patient underwent a successful L4–L5 spondylectomy and lumbopelvic reconstruction using a combined posterior and anterior approach over two operative stages.

Results Postoperative complications included a deep wound infection and a cerebrospinal fluid leak; however, following surgical debridement and long-term antibiotic treatment, the patient was neurologically intact with minimal pain and there was no evidence of tumor recurrence or instrumentation failure at more than 2 years of follow-up.

Conclusion Spondylectomy that achieves en bloc resection is a viable and effective treatment option that can be curative for Enneking stage III GCTs involving the lower lumbar spine. The lumbosacral junction represents a challenging anatomic location for spinal reconstruction after spondylectomy with unique technical considerations.

 
  • References

  • 1 Reid R, Banerjee SS, Sciot R. Giant cell tumor. In: Fletcher CD, Unni KK, Mertens F, , eds. World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of Soft Tissue and Bone. Lyon, France: IARC Press; 2002: 310-312
  • 2 Turcotte RE. Giant cell tumor of bone. Orthop Clin North Am 2006; 37 (1) 35-51
  • 3 Mendenhall WM, Zlotecki RA, Scarborough MT, Gibbs CP, Mendenhall NP. Giant cell tumor of bone. Am J Clin Oncol 2006; 29 (1) 96-99
  • 4 Martin C, McCarthy EF. Giant cell tumor of the sacrum and spine: series of 23 cases and a review of the literature. Iowa Orthop J 2010; 30: 69-75
  • 5 Kawahara N, Tomita K, Murakami H, Demura S, Yoshioka K, Kato S. Total en bloc spondylectomy of the lower lumbar spine: a surgical techniques of combined posterior-anterior approach. Spine (Phila Pa 1976) 2011; 36 (1) 74-82
  • 6 Boriani S, Bandiera S, Casadei R , et al. Giant cell tumor of the mobile spine: a review of 49 cases. Spine (Phila Pa 1976) 2012; 37 (1) E37-E45
  • 7 Boriani S, Weinstein JN, Biagini R. Primary bone tumors of the spine. Terminology and surgical staging. Spine (Phila Pa 1976) 1997; 22 (9) 1036-1044
  • 8 Donthineni R, Boriani L, Ofluoglu O, Bandiera S. Metastatic behaviour of giant cell tumour of the spine. Int Orthop 2009; 33 (2) 497-501
  • 9 Campanacci M, Baldini N, Boriani S, Sudanese A. Giant-cell tumor of bone. J Bone Joint Surg Am 1987; 69 (1) 106-114
  • 10 Clarke MJ, Hsu W, Suk I , et al. Three-level en bloc spondylectomy for chordoma. Neurosurgery 2011; 68 (2, Suppl Operative) 325-333 , discussion 333
  • 11 Gallia GL, Sciubba DM, Bydon A , et al. Total L-5 spondylectomy and reconstruction of the lumbosacral junction. Technical note. J Neurosurg Spine 2007; 7 (1) 103-111
  • 12 Harrop JS, Schmidt MH, Boriani S, Shaffrey CI. Aggressive “benign” primary spine neoplasms: osteoblastoma, aneurysmal bone cyst, and giant cell tumor. Spine 2009; 34 (22, Suppl) S39-S47
  • 13 Abe E, Sato K, Tazawa H , et al. Total spondylectomy for primary tumor of the thoracolumbar spine. Spinal Cord 2000; 38 (3) 146-152
  • 14 Boriani S, De Iure F, Bandiera S , et al. Chondrosarcoma of the mobile spine: report on 22 cases. Spine (Phila Pa 1976) 2000; 25 (7) 804-812
  • 15 Detwiler PW, Porter RW, Crawford NR, Apostolides PJ, Dickman CA. Lumbosacral junction fixation and fusion after complete L-5 spondylectomy. Case report. Neurosurg Focus 1999; 7 (6) e3
  • 16 Heary RF, Vaccaro AR, Benevenia J, Cotler JM. “En-bloc” vertebrectomy in the mobile lumbar spine. Surg Neurol 1998; 50 (6) 548-556
  • 17 Marmor E, Rhines LD, Weinberg JS, Gokaslan ZL. Total en bloc lumbar spondylectomy. Case report. J Neurosurg 2001; 95 (2, Suppl) 264-269
  • 18 Shimada Y, Hongo M, Miyakoshi N , et al. Giant cell tumor of fifth lumbar vertebrae: two case reports and review of the literature. Spine J 2007; 7 (4) 499-505
  • 19 Chi JH, Sciubba DM, Rhines LD, Gokaslan ZL. Surgery for primary vertebral tumors: en bloc versus intralesional resection. Neurosurg Clin N Am 2008; 19 (1) 111-117
  • 20 Fidler MW. Surgical treatment of giant cell tumours of the thoracic and lumbar spine: report of nine patients. Eur Spine J 2001; 10 (1) 69-77
  • 21 Hart RA, Boriani S, Biagini R, Currier B, Weinstein JN. A system for surgical staging and management of spine tumors. A clinical outcome study of giant cell tumors of the spine. Spine (Phila Pa 1976) 1997; 22 (15) 1773-1782 , discussion 1783
  • 22 Sanjay BK, Sim FH, Unni KK, McLeod RA, Klassen RA. Giant-cell tumours of the spine. J Bone Joint Surg Br 1993; 75 (1) 148-154
  • 23 Stener B, Johnsen OE. Complete removal of three vertebrae for giant-cell tumour. J Bone Joint Surg Br 1971; 53 (2) 278-287
  • 24 Tomita K, Kawahara N, Baba H, Tsuchiya H, Fujita T, Toribatake Y. Total en bloc spondylectomy. A new surgical technique for primary malignant vertebral tumors. Spine (Phila Pa 1976) 1997; 22 (3) 324-333
  • 25 Boriani S, Bandiera S, Donthineni R , et al. Morbidity of en bloc resections in the spine. Eur Spine J 2010; 19 (2) 231-241
  • 26 Ruka W, Rutkowski P, Morysiński T , et al. The megavoltage radiation therapy in treatment of patients with advanced or difficult giant cell tumors of bone. Int J Radiat Oncol Biol Phys 2010; 78 (2) 494-498
  • 27 Caudell JJ, Ballo MT, Zagars GK , et al. Radiotherapy in the management of giant cell tumor of bone. Int J Radiat Oncol Biol Phys 2003; 57 (1) 158-165
  • 28 Chakravarti A, Spiro IJ, Hug EB, Mankin HJ, Efird JT, Suit HD. Megavoltage radiation therapy for axial and inoperable giant-cell tumor of bone. J Bone Joint Surg Am 1999; 81 (11) 1566-1573
  • 29 Leggon RE, Zlotecki R, Reith J, Scarborough MT. Giant cell tumor of the pelvis and sacrum: 17 cases and analysis of the literature. Clin Orthop Relat Res 2004; (423) 196-207
  • 30 Hosalkar HS, Jones KJ, King JJ, Lackman RD. Serial arterial embolization for large sacral giant-cell tumors: mid- to long-term results. Spine (Phila Pa 1976) 2007; 32 (10) 1107-1115
  • 31 Lin PP, Guzel VB, Moura MF , et al. Long-term follow-up of patients with giant cell tumor of the sacrum treated with selective arterial embolization. Cancer 2002; 95 (6) 1317-1325
  • 32 Wei F, Liu X, Liu Z , et al. Interferon alfa-2b for recurrent and metastatic giant cell tumor of the spine: report of two cases. Spine (Phila Pa 1976) 2010; 35 (24) E1418-E1422
  • 33 Kaban LB, Troulis MJ, Wilkinson MS, Ebb D, Dodson TB. Adjuvant antiangiogenic therapy for giant cell tumors of the jaws. J Oral Maxillofac Surg 2007; 65 (10) 2018-2024 , discussion 2024
  • 34 Arpornchayanon O, Leerapun T. Effectiveness of intravenous bisphosphonate in treatment of giant cell tumor: a case report and review of the literature. J Med Assoc Thai 2008; 91 (10) 1609-1612
  • 35 Thomas D, Henshaw R, Skubitz K , et al. Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study. Lancet Oncol 2010; 11 (3) 275-280
  • 36 ClinicalTrials.gov (A service of the U.S. National Institutes of Health). Safety and efficacy study of denosumab in patients with recurrent or unresectable giant cell tumor of bone (2008). Available at: http://www.clinicaltrials.gov/ct2/show/NCT00680992?term=denosumab&cond=Giant+cell+tumor+of+bone&rank=1 . Accessed April 13, 2013
  • 37 Hsieh PC, Li KW, Sciubba DM, Suk I, Wolinsky JP, Gokaslan ZL. Posterior-only approach for total en bloc spondylectomy for malignant primary spinal neoplasms: anatomic considerations and operative nuances. Neurosurgery 2009; 65 (6, Suppl) 173-181 , discussion 181
  • 38 Kawahara N, Tomita K, Baba H , et al. Cadaveric vascular anatomy for total en bloc spondylectomy in malignant vertebral tumors. Spine (Phila Pa 1976) 1996; 21 (12) 1401-1407
  • 39 Kawahara N, Tomita K, Murakami H, Demura S. Total en bloc spondylectomy for spinal tumors: surgical techniques and related basic background. Orthop Clin North Am 2009; 40 (1) 47-63 , vi
  • 40 Lastra-Power J, Gokaslan ZL, Sosa IJ. Primary bony spinal lesions: surgery for cure. In: Benzel EC, , ed. Spine Surgery: Techniques, Complication, Avoidance, and Management. Philadelphia, PA: Elsevier; 2005: 1015-1024
  • 41 Tomita K, Kawahara N, Murakami H, Demura S. Total en bloc spondylectomy for spinal tumors: improvement of the technique and its associated basic background. J Orthop Sci 2006; 11 (1) 3-12